Stay updated on MEDI0680 + Durvalumab vs Nivolumab in Advanced Malignancies Clinical Trial
Sign up to get notified when there's something new on the MEDI0680 + Durvalumab vs Nivolumab in Advanced Malignancies Clinical Trial page.

Latest updates to the MEDI0680 + Durvalumab vs Nivolumab in Advanced Malignancies Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedPubMed data section note updated to indicate publications are automatically filled from PubMed. Revision version updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check20 days agoChange DetectedRemoved the government funding status notice that warned about potential delays and NIH operating status; this is a non-critical update that does not affect core study details or participant actions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check35 days agoChange DetectedThe two screenshots show the same Study Details page for NCT02118337 with identical content and layout. No substantive differences are detected.SummaryDifference0.3%

- Check63 days agoChange Detected- Added a government funding/operating status notice and current NIH Clinical Center information; updated version to v3.2.0. - Removed reference to v3.1.0.SummaryDifference1%

- Check71 days agoChange DetectedContent update: terminology refined from 'Clear cell renal carcinoma' to 'Clear cell carcinoma of kidney' with a new version tag v3.1.0.SummaryDifference0.1%

- Check85 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; the Back to Top element was removed.SummaryDifference0.1%

Stay in the know with updates to MEDI0680 + Durvalumab vs Nivolumab in Advanced Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MEDI0680 + Durvalumab vs Nivolumab in Advanced Malignancies Clinical Trial page.